Skip to main content
DGX
NYSE Industrial Applications And Services

Quest Diagnostics Finalizes $500M Senior Notes Offering Due 2036

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$196.63
Mkt Cap
$21.766B
52W Low
$164.65
52W High
$213.5
52W Position info
19% above low
Off High info
7.9% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

DGX sits 19% above its 52-week low of $164.65.

Summary

Quest Diagnostics has finalized the terms for a $500 million offering of 5.000% Senior Notes due 2036, with proceeds intended for general corporate purposes including debt repayment.


Key Events · Financing and Capital Events · DGX

  • Finalized Debt Offering

    Quest Diagnostics finalized the terms for a $500 million offering of 5.000% Senior Notes due 2036.

  • Maturity and Yield

    The notes have a maturity date of June 30, 2036, and an issue price of 98.751% of the principal amount, resulting in a yield of 5.158%.

  • Use of Proceeds

    Proceeds are designated for general corporate purposes, including the repayment of existing indebtedness, specifically mentioning the 3.45% Senior Notes due June 1, 2026.

  • Credit Ratings

    The notes carry investment-grade ratings of Baa1 (Moody's), BBB+ (S&P), and BBB+ (Fitch).


Analysis · DGX · Industrial Applications And Services

This Free Writing Prospectus (FWP) finalizes the terms of Quest Diagnostics' $500 million senior notes offering, initiated via a prior registration statement. The issuance of 5.000% notes maturing in 2036 is a significant financing event, representing a strategic move to manage the company's capital structure. The proceeds are earmarked for general corporate purposes, including the refinancing of existing indebtedness, such as the 3.45% Senior Notes due in June 2026. This proactive debt management, coupled with the company's recent strong financial performance and ongoing share repurchase program, indicates a stable financial position and prudent capital allocation.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DGX was trading at $196.63 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $21.8B. The 52-week trading range was $164.65 to $213.50. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DGX - Latest Insights

DGX
Oct 23, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $241.89
Real-time Price: $259.65 info
Change: +$17.76 (+7%) info
Market Cap: $28.566B info
DGX
Oct 23, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $238.42
Real-time Price: $259.65 info
Change: +$21.23 (+9%) info
Market Cap: $28.566B info
DGX
Oct 22, 2026, 11:46 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $236.45
Real-time Price: $259.65 info
Change: +$23.20 (+10%) info
Market Cap: $28.566B info
DGX
Oct 22, 2026, 6:53 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $236.57
Real-time Price: $259.65 info
Change: +$23.08 (+10%) info
Market Cap: $28.566B info
DGX
Oct 22, 2026, 6:49 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $236.57
Real-time Price: $259.65 info
Change: +$23.08 (+10%) info
Market Cap: $28.566B info